Skip to main content
Erschienen in: Cancer Causes & Control 11/2016

17.10.2016 | Original paper

Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta

verfasst von: Lydia S. Murdiyarso, Melissa Kartawinata, Iffat Jenie, Grace Widjajahakim, Heriawaty Hidajat, Ruth Sembiring, I. Made Nasar, Santoso Cornain, Farid Sastranagara, Ahmad Rusdan Handoyo Utomo

Erschienen in: Cancer Causes & Control | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We sought to evaluate prevalence, age-adjusted distribution, and impact of single and multiple high- and low-risk human papillomavirus (HPV) subtypes and their associations with cervical lesions.

Methods

Data were extracted from 11,224 women who underwent routine screening of HPV genotyping and liquid-based cytology co-testing. Fifteen high-risk (HR) and six low-risk (LR) HPV types were genotyped.

Results

Overall HPV prevalence was 10.7 %, and young women (under 21 years old) harbored highest HPV infection rate (40.38 %). The rate declined in old women 9.49 % (age 30–49) and 6.89 % (age 50 and above). Normal cytology had lowest HPV (5.66 %) compared to low-grade (60.49 %), high-grade (71.96 %) squamous intraepithelial lesions (LSIL and HSIL) and squamous cell carcinoma SCC (86.9 %). LR HPV subtypes were absent in SCC and were consistently lower than HR HPV in LSIL (6.74 vs. 33.54 %) and HSIL (2.12 vs. 51.32 %). Multiple HPV infection was more frequent in young women under 30 years old (10 %) than older women (2 %) and in LSIL (20.2 %), HSIL (18.5 %) than SCC (4.4 %). HR HPV 52, 16, 18, and 58 were the most frequent subtypes in normal, LSIL, and HSIL. Greater or equal proportion of HPV 16, 18, 45, and 52 was found in SCC compared to normal cytology (SCC/normal ratios 4.8, 1.2, 1.6, and 1.7). While important in LSIL and HSIL, HPV58 was not detected in SCC.

Conclusion

Taken together, identification of these HPV types, especially HPV 16, 18, 45, and 52, and their associated cervical lesions may improve cervical cancer preventive strategies in Indonesia.
Literatur
7.
Zurück zum Zitat Wentzensen N, Nason M, Schiffman M et al (2014) No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis 209:855–864. doi:10.1093/infdis/jit577 CrossRefPubMed Wentzensen N, Nason M, Schiffman M et al (2014) No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis 209:855–864. doi:10.​1093/​infdis/​jit577 CrossRefPubMed
8.
Zurück zum Zitat Liu SS, Leung R, Chan K (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin 48:758–764. doi:10.1128/JCM.00989-09 Liu SS, Leung R, Chan K (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin 48:758–764. doi:10.​1128/​JCM.​00989-09
12.
Zurück zum Zitat Hosaka M, Fujita H, Hanley SJ et al (2012) Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. Int J Cancer 132:327–334. doi:10.1002/ijc.27680 CrossRefPubMed Hosaka M, Fujita H, Hanley SJ et al (2012) Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. Int J Cancer 132:327–334. doi:10.​1002/​ijc.​27680 CrossRefPubMed
15.
Zurück zum Zitat Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Indonesia. Summary Report 7 October 2016. Accessed 12 Oct 2016 Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Indonesia. Summary Report 7 October 2016. Accessed 12 Oct 2016
17.
Zurück zum Zitat Panigoro R, Susanto H, Novel SS et al (2013) HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia. Asian Pac J Cancer Prev 14:5843–5847. doi:10.7314/APJCP.2013.14.10.5843 CrossRefPubMed Panigoro R, Susanto H, Novel SS et al (2013) HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia. Asian Pac J Cancer Prev 14:5843–5847. doi:10.​7314/​APJCP.​2013.​14.​10.​5843 CrossRefPubMed
19.
Zurück zum Zitat Wheeler CM, Hunt WC, Cuzick J et al (2012) A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer 132:198–207. doi:10.1002/ijc.27608 CrossRefPubMed Wheeler CM, Hunt WC, Cuzick J et al (2012) A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer 132:198–207. doi:10.​1002/​ijc.​27608 CrossRefPubMed
20.
Zurück zum Zitat Clifford GM, Rana RK, Franceschi S et al (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomark Prev 14:1157–1164. doi:10.1158/1055-9965.EPI-04-0812 CrossRef Clifford GM, Rana RK, Franceschi S et al (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomark Prev 14:1157–1164. doi:10.​1158/​1055-9965.​EPI-04-0812 CrossRef
22.
Zurück zum Zitat Guan P, Howell-Jones R, Li N et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131:2349–2359. doi:10.1002/ijc.27485 CrossRefPubMed Guan P, Howell-Jones R, Li N et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131:2349–2359. doi:10.​1002/​ijc.​27485 CrossRefPubMed
23.
Zurück zum Zitat Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632. doi:10.1002/ijc.22527 CrossRefPubMed Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632. doi:10.​1002/​ijc.​22527 CrossRefPubMed
27.
Zurück zum Zitat Bruni L, Diaz M, Castellsagué X et al (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799. doi:10.1086/657321 CrossRefPubMed Bruni L, Diaz M, Castellsagué X et al (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799. doi:10.​1086/​657321 CrossRefPubMed
28.
Zurück zum Zitat Li N, Franceschi S, Howell-Jones R et al (2010) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927–935. doi:10.1002/ijc.25396 CrossRef Li N, Franceschi S, Howell-Jones R et al (2010) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927–935. doi:10.​1002/​ijc.​25396 CrossRef
29.
Zurück zum Zitat Katki HA, Schiffman M, Castle PE et al (2013) Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Lower Genit Tract Dis 17:S28–S35. doi:10.1097/LGT.0b013e318285423c CrossRef Katki HA, Schiffman M, Castle PE et al (2013) Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Lower Genit Tract Dis 17:S28–S35. doi:10.​1097/​LGT.​0b013e318285423c​ CrossRef
Metadaten
Titel
Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta
verfasst von
Lydia S. Murdiyarso
Melissa Kartawinata
Iffat Jenie
Grace Widjajahakim
Heriawaty Hidajat
Ruth Sembiring
I. Made Nasar
Santoso Cornain
Farid Sastranagara
Ahmad Rusdan Handoyo Utomo
Publikationsdatum
17.10.2016
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 11/2016
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0816-4

Weitere Artikel der Ausgabe 11/2016

Cancer Causes & Control 11/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.